सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Ledipasvir-sofosbuvir + Rifampin

गंभीरता: निषिद्ध

Ledipasvir-sofosbuvir and Rifampin: contraindicated interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Rifampin markedly induces P-glycoprotein and lowers sofosbuvir and ledipasvir exposure, which can compromise the antiviral response and cause treatment failure. The interaction is well recognized in labeling.

इस इंटरैक्शन का सरल भाषा में अर्थ

Ledipasvir-sofosbuvir and Rifampin are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

साक्ष्य स्तर: High

ऐसा क्यों होता है

Rifampin induces intestinal P-glycoprotein, reducing absorption and plasma concentrations of sofosbuvir and ledipasvir.

क्या करें

Do not co-administer. Defer rifampin-containing therapy or select an alternative agent, or postpone hepatitis C treatment until rifampin is stopped.

फार्मासिस्ट से क्या पूछें

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Ledipasvir-sofosbuvir और Rifampin की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Ledipasvir-sofosbuvir with Rifampin?

MediHelp rates the interaction as contraindicated. Ledipasvir-sofosbuvir and Rifampin are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Rifampin markedly induces P-glycoprotein and lowers sofosbuvir and ledipasvir exposure, which can compromise the antiviral response and cause treatment failure. The interaction is well recognized in labeling.

How serious is the interaction between Ledipasvir-sofosbuvir and Rifampin?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not co-administer. Defer rifampin-containing therapy or select an alternative agent, or postpone hepatitis C treatment until rifampin is stopped.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन